Last reviewed · How we verify

NCT03966937

Trigger Point Dry Needling In Patient With Patellofemoral Pain Syndrome

Completed NA Last updated 9 August 2019
What this trial tests

NA trial testing Dry needling in Patellofemoral Pain Syndrome in 70 participants. Completed in 30 June 2019.

Timeline
19 March 2019
Primary endpoint
30 June 2019
30 June 2019

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment70
Start date19 March 2019
Primary completion30 June 2019
Estimated completion30 June 2019
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 35, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to determine the effects of trigger point dry needling in patients with Patellofemoral pain Syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry needling

Trials testing the same drug.

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing